- Report
- January 2024
- 285 Pages
Global
From €9175EUR$9,500USD£7,852GBP
- Report
- June 2018
- 15 Pages
Global
From €9658EUR$10,000USD£8,265GBP
The Nouriast market is a segment of the Central Nervous System (CNS) drugs market. It is composed of drugs used to treat neurological disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and epilepsy. These drugs are used to improve the quality of life of patients suffering from these conditions. The Nouriast market is highly competitive, with a wide range of products available from different manufacturers. The market is also characterized by high prices, due to the complexity of the drugs and the need for specialized medical care.
The Nouriast market is dominated by large pharmaceutical companies such as Pfizer, Merck, and Novartis. Other major players include GlaxoSmithKline, Sanofi, and Johnson & Johnson. Smaller companies such as Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals also have a presence in the market. Show Less Read more